Détention brevets de la classe A61K 35/35

Brevets de cette classe: 625

Historique des publications depuis 10 ans

81
63
71
59
67
66
55
48
22
16
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Shanghai Seme Cell Technology Co., Ltd
36
24
RegenLab USA LLC
77
13
LifeCell Corporation
336
12
Lipogems International S.p.A.
27
9
Musculoskeletal Transplant Foundation
223
8
Rohto Pharmaceutical Co., Ltd.
409
8
GID bio, Inc.
22
8
Amnio Technology, LLC
43
7
BioRestorative Therapies, Inc.
17
7
Pluri Biotech Ltd.
55
7
The Regents of the University of California
20556
6
The Johns Hopkins University
5821
6
Takeda Pharmaceutical Company Limited
2721
6
The Brigham and Women's Hospital, Inc.
2264
6
Kyoto Prefectural Public University Corporation
252
6
University of Pittsburgh - Of the Commonwealth System of Higher Education
3263
6
Neosyad
15
6
Calidi Biotherapeutics (Nevada), Inc.
17
6
The Board of Trustees of the Leland Stanford Junior University
6592
5
The General Hospital Corporation
4824
5
Autres propriétaires 464